Valproate and GABAergic System Effects [2]

Neuropsychopharmacology

Volumn 28, Issue 11, 2003, Pages 2050-2051

  Winterer, Georg ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BICUCULLINE; VALPROIC ACID;

CLINICAL TRIAL; DOPAMINERGIC TRANSMISSION; DRUG MECHANISM; GABAERGIC TRANSMISSION; HIPPOCAMPUS; HUMAN; LETTER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PSYCHOPHARMACOTHERAPY; SCHIZOPHRENIA; SEDATION; TREATMENT OUTCOME;

EID: 0242725534     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300245     Document Type: Letter

References (16)

1. Albus H, Williamson R (1998). Electrophysiologic analysis of the actions of valproate on pyramidal neurons in the rat hippocampal slice. Epilepsia 39: 124-139.
2. Benes FM, Beretta S (2001). GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 25: 1-27.
3. Casey DE, Daniel DG, Wassef AA, Tracy AA, Wozniak P, Sommerville KW (2003). Effect of divalproex combined with olanzepine or risperidone in patients with an acute exacerbation of schizophrenia. Neuropsychopharmacology 28: 182-192.
4. Citrome L, Levine J, Allingham B (2000). Changes in use of valproate and other mood stabilizers for patients with schizophrenia from 1994 to 1998. Psychiatr Serv 51: 634-638.
5. Emrich HM, von Zerssen D, Kissling W, Möller HJ, Windorfer A (1980). Effect of sodium valproate on mania. The GABA-hypothesis of affective disorders. Arch Psychiatr Nerven 229: 1-16.
6. Goden Y, Heiner L, Mark J, Mandel P (1969). Effects of di-n-propylacetate, an anticonvulsant compound, on GABA metabolism. J Neurochem 16: 69-73.
7. Ko GN, Korpi ER, Freed WJ, Zalcman SJ, Bigelow LB (1985). Effects of valproic acid on behavior and plasma concentration in chronic schizophrenic patients. Biol Psychiatry 20: 209-215.
8. Lewis DA (2000). GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia. Brain Res Brain Res Rev 31: 270-276.
9. Löscher W (1981). Effect of inhibitors of GABA aminotransferase on the metabolism of GABA in brain tissue and synaptosomal fractions. J Neurochem Res 36: 1521-1527.
10. Perreault P, Tancredi V, Avoli M (1989). Failure of the antiepileptic drug valproic acid to modify synaptic and non-synaptic responses of CA1 hippocampal pyramidal cells maintained 'in vitro'. Epilepsy Res 3: 227-231.
11. Preisendörfer U, Zeise ML, Klee MR (1987). Valproate enhances inhibitory postsynaptic potentials in hippocampal neurons in vitro. Brain Res 435: 213-219.
12. Sawaya MCB, Horton RW, Meldrun BS (1975). Effects of anticonvulsant drugs on the cerebral enzymes metabolizing GABA. Epilepsia 16: 649-655.
13. Swann AC, Petty F, Bowden CL, Dilsaver SC, Calabrese JR, Morris D (1999). Mania: gender, transmitter function, and response to treatment. Psychiatr Res 88: 55-61.
14. Wassef AA, Dott SG, Harris A, Brown A, O'Boyle M, Meyer III WJ (1999). Critical review of GABAergic drugs on the treatment of schizophrenia. J Clin Psychopharmacol 19: 222-232.
15. Wassef AA, Dott SG, Harris A, Brown A, O'Boyle M, Meyer III WJ (2000). Randomized, placebo-controlled pilot study of divalproex sodium in the treatment of acute exacerbations of chronic schizophrenia. J Clin Psychopharmacol 20: 357-361.
16. Winterer G, Herrmann WM (2000). Valproate and the symptomatic treatment of schizophrenia spectrum patients. Pharmacopsychiatry 33: 182-188.